Expertise in
17
conditions

Dr. Bruno Medeiros

Hematology
Stanford University
875 Blake Wilbur Dr, 
Palo Alto, CA 
Expertise in
17
conditions
Stanford University
875 Blake Wilbur Dr, 
Palo Alto, CA 

Overview

Bruno Medeiros is a Hematologist in Palo Alto, California. Dr. Medeiros is highly rated in 17 conditions, according to our data. His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Acute Myeloblastic Leukemia without Maturation, Bone Marrow Aspiration, and Bone Marrow Transplant.

His clinical research consists of co-authoring 147 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Hematology

Licenses

Internal Medicine in CA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Cigna
  • EPO
  • HMO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D

Locations

Stanford University
875 Blake Wilbur Dr, Palo Alto, CA 94304
Other Locations
Stanford Hospital and Clinics
965 High St, Palo Alto, CA 94301

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomized, Open Label, Phase 2 Study of the Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) Versus Specified Physician's Choice in Patients ≥ 60 Years Old With Relapsed or Refractory Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy and/or Transplantation
A Randomized, Open Label, Phase 2 Study of the Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) Versus Specified Physician's Choice in Patients ≥ 60 Years Old With Relapsed or Refractory Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy and/or Transplantation
Enrollment Status: Completed
Publish Date: January 26, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Phase II Study of CPX-351 for Treatment of AML or Higher Risk MDS Relapsed or Refractory to Prior Therapy With Hypomethylating (HMA) Agent
A Phase II Study of CPX-351 for Treatment of AML or Higher Risk MDS Relapsed or Refractory to Prior Therapy With Hypomethylating (HMA) Agent
Enrollment Status: Completed
Publish Date: January 22, 2019
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2 Study of Decitabine in Combination With Midostaurin (PKC412) for Elderly Patients With Newly Diagnosed FLT3-ITD/TKD Positive Acute Myeloid Leukemia
A Phase 2 Study of Decitabine in Combination With Midostaurin (PKC412) for Elderly Patients With Newly Diagnosed FLT3-ITD/TKD Positive Acute Myeloid Leukemia
Enrollment Status: Terminated
Publish Date: September 27, 2018
Intervention Type: Drug
Study Phase: Phase 2
A Phase I Dose Escalation Study of Ibrutinib With Idarubicin/Cytarabine for Relapsed/Refractory Acute Myeloid Leukemia
A Phase I Dose Escalation Study of Ibrutinib With Idarubicin/Cytarabine for Relapsed/Refractory Acute Myeloid Leukemia
Enrollment Status: Terminated
Publish Date: May 14, 2018
Intervention Type: Drug
Study Phase: Phase 1
View 3 Less Clinical Trials

147 Total Publications

Erratum: Rapid Donor Identification Improves Survival in High-Risk First-Remission Patients With Acute Myeloid Leukemia.
Erratum: Rapid Donor Identification Improves Survival in High-Risk First-Remission Patients With Acute Myeloid Leukemia.
Journal: JCO oncology practice
Published: March 20, 2025
Similar Doctors
Expertise in
42
conditions
Dr. Jason Gotlib
Hematology
Expertise in
42
conditions
Dr. Jason Gotlib
Hematology

Stanford University

875 Blake Wilbur Dr, 
Palo Alto, CA 
 (0.3 miles away)
650-498-6000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jason Gotlib is a Hematologist in Palo Alto, California. Dr. Gotlib is highly rated in 42 conditions, according to our data. His top areas of expertise are Systemic Mastocytosis, Mast Cell Activation Syndrome (MCAS), Myelofibrosis, Bone Marrow Aspiration, and Tissue Biopsy.

Expertise in
23
conditions
Dr. Bertil Glader
Hematology
Expertise in
23
conditions
Dr. Bertil Glader
Hematology

Lucile Packard Children's Hospital Stanford

725 Welch Rd, 
Palo Alto, CA 
 (0.3 miles away)
650-497-8953
Languages Spoken:
English
See accepted insurances

Bertil Glader is a Hematologist in Palo Alto, California. Dr. Glader is highly rated in 23 conditions, according to our data. His top areas of expertise are Aase Syndrome, Pyruvate Kinase Deficiency, Pure Red Cell Aplasia, Hemolytic Anemia, and Splenectomy.

Expertise in
37
conditions
Dr. David Miklos
Hematology
Expertise in
37
conditions
Dr. David Miklos
Hematology

Stanford Hospital And Clinics

300 Pasteur Dr, 
Stanford, CA 
 (0.1 miles away)
650-723-0822
Languages Spoken:
English
See accepted insurances
Offers Telehealth

David Miklos is a Hematologist in Stanford, California. Dr. Miklos is highly rated in 37 conditions, according to our data. His top areas of expertise are Chronic Graft Versus Host Disease (cGvHD), B-Cell Lymphoma, Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Frequently Asked Questions about Dr. Bruno Medeiros

How do I make an appointment with Dr. Bruno Medeiros?

You can book an appointment with Dr. Bruno Medeiros by calling their office at 650-498-6000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Bruno Medeiros a top-rated expert for Acute Myeloid Leukemia (AML)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Bruno Medeiros is classified as an Elite expert for Acute Myeloid Leukemia (AML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Bruno Medeiros specialize in?

While Dr. Bruno Medeiros is a Hematology, they have specific expertise in Acute Myeloid Leukemia (AML), Leukemia, and Acute Myeloblastic Leukemia without Maturation. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Bruno Medeiros participate in research or clinical trials?

Yes. Dr. Bruno Medeiros has published 147 articles and abstracts on conditions like Acute Myeloid Leukemia (AML). You can view a list of Dr. Bruno Medeiros's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Bruno Medeiros accept my insurance?

Dr. Bruno Medeiros accepts most major insurance plans, including Cigna and Wellcare. We recommend calling the office directly at 650-498-6000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Medeiros's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 21 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile